September 19, 2015 – The American Food and Drug Administration (FDA) just approved Cariprazine (Vraylar) capsules to treat schizophrenia and bipolar disorder in adults. Schizophrenia is a chronic, severe and disabling brain disorder affecting about one percent of Americans. Typically, …

Cariprazine (Vraylar): New treatment for schizophrenia and bipolar disorder approved Read more »